The COL10A1 gene gives growing bones instructions to make type X collagen, a support protein used in the growth plates near the ends of bones. This gene helps your body turn cartilage into bone during childhood growth. Pathogenic variants in the COL10A1 gene can cause a skeletal condition called Schmid metaphyseal chondrodysplasia, which may lead to short stature, bowed legs, and hip or knee discomfort. Symptoms and severity can vary from person to person.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, which serve as the working parts of cells. Other genes are mainly involved in controlling when certain processes happen, where they happen, and how strongly they run. Taken together, genes affect how the body develops and works, and they can shape how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
COL10A1Gene function
What if the gene works
The COL10A1 gene helps make type X collagen, a protein used in growth plate cartilage. This supports normal bone growth as children's cartilage is gradually replaced by bone.
Risk
What if the gene does not work
Variants in the COL10A1 gene most often cause Schmid metaphyseal chondrodysplasia, a bone growth condition with short stature and bowed legs. Milder or more severe variants can change when signs appear and how noticeable they are.
Treatment
What does that mean for your treatment
No COL10A1-specific treatment or management approach is currently established for pathogenic variants in the COL10A1 gene. In research, the COL10A1 gene is being studied mainly as a tissue marker and possible biomarker in some cancers, rather than as a validated treatment target.
Conditions associated with COL10A1
Gene function
What if the gene works
Bone lengthening depends on a smooth handoff from cartilage to bone at the growth plates near the ends of long bones. In this area, the COL10A1 gene helps build a specialized support protein used by maturing cartilage cells. That protein supports normal bone growth during childhood and adolescence.
The COL10A1 gene helps make collagen X, a support protein used in maturing cartilage at the growth plate. This gives the tissue a firm framework as bones lengthen and take shape.
Its protein supports cartilage turning into bone during growth, especially in the deeper part of the growth plate. It helps the tissue reach the stage where minerals are added and bone can form in an orderly way.
Collagen X collects around cartilage cells that have reached their final growth stage. This helps create the right local environment for normal bone development in childhood and adolescence.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help explain normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
Variants in the COL10A1 gene often change the type X collagen chain so it folds poorly, cannot join its partner chains normally, or is cleared before it reaches cartilage. This explains how COL10A1 gene variants affect bone growth: they weaken the cartilage matrix around growth plate cells. Some variants have a milder effect on collagen assembly, while more disruptive variants can reduce secretion more sharply and may be linked to earlier or more marked Schmid metaphyseal chondrodysplasia.
How variants are linked to conditions
Pathogenic variants in the COL10A1 gene cause metaphyseal chondrodysplasia, Schmid type, a condition affecting bone growth. People with this COL10A1 gene condition often have short stature, bowed legs, and hip or knee pain, although the severity can vary from person to person. When a disease-causing variant is found in the COL10A1 gene, it can confirm the diagnosis in someone with matching clinical features.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are found commonly across the general population. Most do not directly affect health and instead reflect the natural range of human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a confirmed diagnosis, particularly when multiple genes and environmental factors also contribute. In some cases, though, a single well understood variant in a specific gene is enough to confirm the diagnosis.
Are there things that can increase or change my risk?
For COL10A1, there is not broadly confirmed evidence that lifestyle or everyday exposures clearly increase or reduce risk. If someone carries a disease-causing change in the COL10A1 gene, the chance of developing the related bone growth condition is mainly linked to that inherited change rather than modifiable factors.
Inheritance of COL10A1 variants
Changes in the COL10A1 gene linked to Schmid type metaphyseal chondrodysplasia are usually inherited in an autosomal dominant pattern. This means a child can inherit the condition if one parent carries a disease causing variant in the COL10A1 gene, and each pregnancy has a 50% chance of passing it on. Some people have a new, de novo variant in the COL10A1 gene, so they are the first person in the family to have it. This is the main COL10A1 inheritance pattern recognized for this condition.
What does my COL10A1 result mean for my family?
For families with a disease-causing change in the COL10A1 gene, the pattern is usually dominant, which means close relatives such as a parent, brother, sister, or child may also carry the same change and may have similar bone growth findings, though severity can differ. Because of that, family members may want to discuss whether the result is relevant to them and their children.
Genetic information
Genetic testing
How you find out about variants
COL10A1 genetic testing looks for DNA variants in the COL10A1 gene, usually from a blood or saliva sample. A laboratory reads the gene's code to check for changes linked to Schmid metaphyseal chondrodysplasia. This explains how genetic testing for COL10A1 variants works and how a pathogenic variant can be confirmed.
When should I consider getting a genetic test?
Consider testing for changes in the COL10A1 gene if you or your child has a rare inherited bone growth condition with short stature, bowed legs, hip or knee pain, or a waddling walk, especially when it runs in the family. Testing can help confirm whether COL10A1 is the cause.
A genetic result is only one part of your health story
A genetic result can be very informative, but how much it explains varies by the condition and by the specific type of variant. How the body functions over time is also shaped by many other factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when viewed together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help make sense of a person’s individual experience.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, breaks down, or responds to a drug, so the same treatment may work better for one person than for another. This is common and can influence how much benefit someone gets or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medicines. It looks at the relationship between genes and drugs to better understand why the same treatment may work differently from one person to another. For many medications, genes can affect both how strongly a drug works and how the body processes it. This understanding can help support more informed, individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the COL10A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines, so general health concerns, treatment questions, and any new or worrying side effects are best discussed with your doctor or pharmacist.
History
COL10A1 entered medical genetics through studies of bone growth and growth plate cartilage in the late 20th century. In the 1980s, researchers identified type X collagen as a protein made mainly by cartilage cells involved in the last stages of bone formation. Building on this early work, scientists cloned the COL10A1 gene and mapped it to chromosome 6. In the 1990s, variants in the COL10A1 gene were linked to Schmid metaphyseal chondrodysplasia, a condition that affects bone growth and can lead to short stature and bowed legs. That finding helped connect a specific collagen gene to a recognizable skeletal condition. Over time, descriptions became more precise as additional families and variants were reported.